Your browser doesn't support javascript.
loading
Virus inactivation at moderately low pH varies with virus and buffer properties.
Joshi, Pratik U; Meingast, Christa L; Xu, Xuankuo; Holstein, Melissa; Feroz, Hasin; Ranjan, Swarnim; Ghose, Sanchayita; Li, Zheng Jian; Heldt, Caryn L.
Afiliação
  • Joshi PU; Department of Chemical Engineering, Michigan Technological University, Houghton, Michigan, USA.
  • Meingast CL; Health Research Institute, Michigan Technological University, Houghton, Michigan, USA.
  • Xu X; Health Research Institute, Michigan Technological University, Houghton, Michigan, USA.
  • Holstein M; Department of Environmental Engineering, Michigan Technological University, Houghton, Michigan, USA.
  • Feroz H; Biologics Process Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, Massachusetts, USA.
  • Ranjan S; Biologics Process Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, Massachusetts, USA.
  • Ghose S; Biologics Process Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, Massachusetts, USA.
  • Li ZJ; Biologics Process Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, Massachusetts, USA.
  • Heldt CL; Biologics Process Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, Massachusetts, USA.
Biotechnol J ; 17(2): e2100320, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34874097
ABSTRACT

BACKGROUND:

Virus inactivation is a critical operation in therapeutic protein manufacturing. Low pH buffers are a widely used strategy to ensure robust enveloped virus clearance. However, the choice of model virus can give varying results in viral clearance studies. Pseudorabies virus (SuHV) or herpes simplex virus-1 (HSV-1) are frequently chosen as model viruses to demonstrate the inactivation for the herpes family.

RESULTS:

In this study, SuHV, HSV-1, and equine arteritis virus (EAV) were used to compare the inactivation susceptibility at pH 4.0 and 4°C. SuHV and HSV-1 are from the same family, and EAV was chosen as a small, enveloped virus. Glycine, acetate, and citrate buffers at pH 4.0 and varying buffer strengths were studied. The inactivation susceptibility was found to be in the order of SuHV > HSV > EAV. The buffer effectiveness was found to be in the order of citrate > acetate > glycine. The smaller virus, EAV, remained stable and infectious in all the buffer types and compositions studied.

CONCLUSION:

The variation in inactivation susceptibility of herpes viruses indicated that SuHV and HSV cannot be interchangeably used as a virus model for inactivation studies. Smaller viruses might remain adventitiously infective at moderately low pH.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus / Herpesvirus Humano 1 Limite: Animals Idioma: En Revista: Biotechnol J Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus / Herpesvirus Humano 1 Limite: Animals Idioma: En Revista: Biotechnol J Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos